Genome response to tissue plasminogen activator in experimental ischemic stroke

被引:13
|
作者
Jickling, Glen C. [1 ,2 ]
Zhan, Xinhua [1 ,2 ]
Ander, Bradley P. [1 ,2 ]
Turner, Renee [1 ,2 ]
Stamova, Boryana [1 ,2 ]
Xu, Huichun [1 ,2 ]
Tian, Yingfang [1 ,2 ]
Liu, Dazhi [1 ,2 ]
Davis, Ryan R. [1 ,2 ]
Lapchak, Paul A. [3 ]
Sharp, Frank R. [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA
[3] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
来源
BMC GENOMICS | 2010年 / 11卷
关键词
BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; INTRACEREBRAL HEMORRHAGE; MATRIX-METALLOPROTEINASE; THROMBOLYTIC THERAPY; CELLS; MATRIX-METALLOPROTEINASE-9; NEUTROPHILS; DISRUPTION; MONOCYTES;
D O I
10.1186/1471-2164-11-254
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke. Results: tPA differentially expressed 929 genes in the blood of rats (p <= 0.05, fold change >= vertical bar 1.2 vertical bar). Genes identified had functions related to modulation of immune cells. tPA gene expression was found to be dependent on the reperfusion status of cerebral vasculature. The majority of genes regulated by tPA were different from genes regulated by ischemic stroke. Conclusions: tPA modulates gene expression in the blood of rats involving immune cells in a manner that is dependent on the status of vascular reperfusion. These non-fibrinolytic activities of tPA in the blood serve to better understand tPA-related complications.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen
    Qureshi, AI
    Suri, MFK
    Shatla, AA
    Ringer, AJ
    Fessler, RD
    Ali, Z
    Guterman, LR
    Hopkins, LN
    NEUROSURGERY, 2000, 47 (02) : 473 - 476
  • [22] Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review
    Ramaiah, Siva Seeta
    Yan, Bernard
    CEREBROVASCULAR DISEASES, 2013, 36 (03) : 161 - 166
  • [23] Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?
    Siniscalchi, Antonio
    Sanguigni, Sandro
    Lochner, Piergiorgio
    De Sarro, Giovambattista
    Malferrari, Giovanni
    Gallelli, Luca
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (03) : 302 - 303
  • [24] Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital
    Figueroa-Reyes, Tatiana
    Saez M, David
    Mansilla L, Eloy
    Sanchez, Rodrigo, V
    Nogales-Gaete, Jorge
    Delgado B, Iris
    REVISTA MEDICA DE CHILE, 2011, 139 (09) : 1118 - 1127
  • [25] Spinal subdural hematoma following tissue plasminogen activator treatment for acute ischemic stroke
    Kim, So-Hyun
    Choi, Seong Hye
    Song, Eun Cheol
    Rha, Joung-Ho
    Kim, Sung Rae
    Park, Hyoung Chun
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 273 (1-2) : 139 - 141
  • [26] Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke
    Wang, XY
    Tsuji, K
    Lee, SR
    Ning, MM
    Furie, KL
    Buchan, AM
    Lo, EH
    STROKE, 2004, 35 (11) : 2726 - 2730
  • [27] Minocycline and Tissue-Type Plasminogen Activator for Stroke Assessment of Interaction Potential
    Machado, Livia S.
    Sazonova, Irina Y.
    Kozak, Anna
    Wiley, Daniel C.
    El-Remessy, Azza B.
    Ergul, Adviye
    Hess, David C.
    Waller, Jennifer L.
    Fagan, Susan C.
    STROKE, 2009, 40 (09) : 3028 - 3033
  • [28] Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke
    Zhang, Shuoqi
    Cao, Yuze
    Du, Jingwen
    Liu, Huan
    Chen, Xiaojing
    Li, Mengdi
    Xiang, Mengqi
    Wang, Chengyue
    Wu, Xiaoming
    Liu, Langjiao
    Wang, Chunli
    Wu, Yinsong
    Li, Zhuxin
    Fang, Shaohong
    Shi, Jialan
    Wang, Lihua
    FASEB JOURNAL, 2021, 35 (09)
  • [29] Intravenous tissue plasminogen activator for acute ischemic stroke - A Canadian hospital's experience
    Chapman, KM
    Woolfenden, AR
    Graeb, D
    Johnston, DCC
    Beckman, J
    Schulzer, M
    Teal, PA
    STROKE, 2000, 31 (12) : 2920 - 2924
  • [30] Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
    Balami, Joyce S.
    Sutherland, Brad A.
    Buchan, Alastair M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (02) : 155 - 169